AI in Drug Development helps Pharma Cut Trial Admin Time
AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.
by Maggie Fick and Michael Erman | Reuters | 26 January 2026 | Feb 3, 2026 | Archive, January 2026
AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.
You must be a subscriber to access all of this content.
by Robert Langreth & Damian Garde | Bloomberg | 1 June 2025 | Jun 29, 2025 | Archive, June 2025
Explore immunotherapy for cancer and its transformative impact on treatment at earlier stages, improving survival rates.
You must be a subscriber to access all of this content.